Comparing the Effect of tDCS With CBT Interventions on the stress and anxiety and depression and relapse in abstinent methamphetamine-dependent subjects

Comparing the Effect of Transcranial Direct Current Stimulation (tDCS) With Cognitive-Behavioral therapy (CBT) Interventions on the stress and anxiety and depression and relapse in abstinent methamphetamine-dependent subjects in Farabi Hospital.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120502009620N2

Enrollment

Registered

2022-07-13

Start date

2022-07-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine addiction. Other stimulant dependence

Interventions

Intervention 1: Intervention group: 1- tDCS: Oasis Pro tDCS from Mind Alive Canada will be used to stimulate direct current stimulation. Anode or excitation electrode with dimensions of 25cm2 (5 * 5 c

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male Right-hand Has a minimum education level of diploma Age over 18 years Has a minimum 6 months Methamphetamine use before treatment During Methamphetamine abstinence

Exclusion criteria

Exclusion criteria: Drug interventions Existence of metal in head and neck History of seizures The presence of a pacemaker in the heart Psychiatric disorders Addiction Alcohol consumption Consumption of sedatives

Design outcomes

Primary

Measure	Time frame
Stress score in DASS test. Timepoint: Stress scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Anxiety score in DASS test. Timepoint: Anxiety scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Depression score in DASS test. Timepoint: Depression scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Relapse score in the Persian version of the AWAER questionnaire. Timepoint: Relapse score will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: Persian version of the AWAER questionnaire.;Salivary cortisol level. Timepoint: Salivary cortisol level will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current	—

Measure

Time frame

Stress score in DASS test. Timepoint: Stress scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Anxiety score in DASS test. Timepoint: Anxiety scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Depression score in DASS test. Timepoint: Depression scores will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: D?ASS-21 Stress, Anxiety and Depression Questionnaire.;Relapse score in the Persian version of the AWAER questionnaire. Timepoint: Relapse score will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current stimulation intervention and after 24 sessions of cognitive-behavioral therapy intervention. All tests will be repeated 4 months after the end of the study to follow the therapeutic effects. Method of measurement: Persian version of the AWAER questionnaire.;Salivary cortisol level. Timepoint: Salivary cortisol level will be measured at the beginning of the study, ie one week before the intervention and after 10 sessions of direct current

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahereh Sadat Javadifar

Kermanshah University of Medical Sciences

tjavadifar@yahoo.com+98 83 3836 2532

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026